These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25193244)

  • 1. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?
    Lavoie J; Hébert M; Beaulieu JM
    Biol Psychiatry; 2015 Feb; 77(3):e15-e17. PubMed ID: 25193244
    [No Abstract]   [Full Text] [Related]  

  • 2. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders.
    Lavoie J; Illiano P; Sotnikova TD; Gainetdinov RR; Beaulieu JM; Hébert M
    Biol Psychiatry; 2014 Mar; 75(6):479-86. PubMed ID: 23305992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.
    Chen G; Henter ID; Manji HK
    Biol Psychiatry; 2014 Jul; 76(2):86-8. PubMed ID: 24948381
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.
    Lavoie J; Hébert M; Beaulieu JM
    Biol Psychiatry; 2014 Jul; 76(2):93-100. PubMed ID: 24138923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.
    Beaulieu JM
    J Psychiatry Neurosci; 2012 Jan; 37(1):7-16. PubMed ID: 21711983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the subsecond dynamics of neurotransmission of dopamine and serotonin.
    Jennings KA
    ACS Chem Neurosci; 2013 May; 4(5):704-14. PubMed ID: 23627553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
    Martí Y; Matthaeus F; Lau T; Schloss P
    Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
    Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
    Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired prepulse inhibition in mice with IRSp53 deletion in modulatory neurotransmitter neurons including dopamine, acetylcholine, oxytocin, and serotonin.
    Kim Y; Yang E; Kim H
    Biochem Biophys Res Commun; 2022 Jan; 586():114-120. PubMed ID: 34839189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
    World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation.
    Benedetti F; Dallaspezia S; Lorenzi C; Pirovano A; Radaelli D; Locatelli C; Poletti S; Colombo C; Smeraldi E
    J Affect Disord; 2012 Feb; 136(3):514-9. PubMed ID: 22119086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF; Huang MC; Liu HC
    J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
    Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E
    Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment.
    de Bartolomeis A; Buonaguro EF; Iasevoli F; Tomasetti C
    J Psychopharmacol; 2014 Jun; 28(6):505-26. PubMed ID: 24554693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
    Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
    Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
    Scassellati C; Rotondo A; Bonvicini C; Rossi G; Cassano GB; Gennarelli M
    Psychiatr Genet; 2007 Aug; 17(4):249-50. PubMed ID: 17621172
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased reactivity and monoamine dysregulation following stress in triploid Atlantic salmon (Salmo salar).
    Fraser TW; Vindas MA; Fjelldal PG; Winberg S; Thörnqvist PO; Øverli Ø; Skjæraasen JE; Hansen TJ; Mayer I
    Comp Biochem Physiol A Mol Integr Physiol; 2015 Jul; 185():125-31. PubMed ID: 25882085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
    Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.